Loading...
Biomarkers and surrogate endpoints in kidney disease
Kidney disease and its related comorbidities impose a large public health burden. Despite this, the number of clinical trials in nephrology lags behind many other fields. An important factor contributing to the relatively slow pace of nephrology trials is that existing clinical endpoints have signif...
Na minha lista:
| Udgivet i: | Pediatr Nephrol |
|---|---|
| Hovedforfatter: | |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2015
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4646734/ https://ncbi.nlm.nih.gov/pubmed/25980469 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00467-015-3104-8 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|